Bio-Works Technologies AB (publ), a biotechnology company, engages in the research, development, manufacture, and supply of agarose-based separation products to purify proteins, enzymes, antibodies, peptides, and other biomolecules primarily in Sweden. It offers activated and affinity resins; hydrophobic interaction chromatography resins; GoBio Mini columns; immobilized metal-ion affinity chromatography resins; ion exchange resins; desalting columns; RoboColumns and Optimo PRO 96 well screens; screening kits; and size exclusion chromatography resins. The company’s products are used in antibodies, his-tagged proteins, proteins, peptides, oligonucleotides, and viruses and vaccines applications. Bio-Works Technologies AB (publ) founded in 2006 and is headquartered in Uppsala, Sweden.
Metrics to compare | BIOWKS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBIOWKSPeersSector | |
---|---|---|---|---|
P/E Ratio | −7.0x | −2.9x | −0.5x | |
PEG Ratio | −0.11 | 0.05 | 0.00 | |
Price/Book | 6.4x | 1.6x | 2.6x | |
Price / LTM Sales | 7.1x | 1,631.2x | 3.3x | |
Upside (Analyst Target) | - | 0.0% | 43.5% | |
Fair Value Upside | Unlock | −6.2% | 6.9% | Unlock |